High-dose methylprednisolone influences the physiology and virulence of Candida albicans ambiguously and enhances the candidacidal activity of the polyene antibiotic amphotericin B and the superoxide-generating agent menadione

FEMS Yeast Research

Volumn 7, Issue 2, 2007, Pages 265-275

  Gyetvai, Ágnes ^a   Emri, Tamás ^a   Fekete, Andrea ^a   Varga, Zsuzsa ^b   Gazdag, Zoltán ^c   Pesti, Miklós ^c   Belágyi, József ^d   Emõdy, Levente ^d   Pócsi, István ^a   Lenkey, Béla ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d UNIVERSITY OF PÉCS   (Hungary)

Author keywords

Amphotericin B; Candida albicans; Menadione; Methylprednisolone; Nystatin; Virulence factors

Indexed keywords

AMPHOTERICIN B; MENADIONE; METHYLPREDNISOLONE;

ARTICLE; CANDIDA ALBICANS; DRUG ACTIVITY; DRUG POTENTIATION; HUMAN; LEUKOCYTE; MICROBIAL GROWTH; NONHUMAN; PATHOGENESIS; POLYMORPHONUCLEAR CELL; VIRULENCE;

AMPHOTERICIN B; ANIMALS; ANTIFUNGAL AGENTS; ANTIOXIDANTS; CANDIDA ALBICANS; CANDIDIASIS; CELL MEMBRANE PERMEABILITY; DRUG INTERACTIONS; FEMALE; GLUCOCORTICOIDS; LIPID PEROXIDATION; METHYLPREDNISOLONE; MICE; MICROBIAL SENSITIVITY TESTS; OXIDATIVE STRESS; VIRULENCE; VITAMIN K 3; VITAMINS;

CANDIDA ALBICANS; FUNGI;

EID: 33846954382     PISSN: 15671356     EISSN: 15671364     Source Type: Journal    
DOI: 10.1111/j.1567-1364.2006.00179.x     Document Type: Article

References (75)

1. Aoki S, Ito-Kuwa S, Nakamura Y & Masuhara T (1990) Comparative pathogenicity of a wild-type strain and respiratory mutants of Candida albicans. Zentralbl Bakteriol 273: 332-343.
2. Babior BM, Kipnes RS & Curnutte JT (1973) Biological defence mechanism. The production by leukocytes of superoxide, a potential bactericidal agent. J Clin Invest 52: 741-744.
3. Balla G, Jacob HS, Eaton JW, Belcher JD & Vercellotti GM (1991) Hemin: a possible physiological mediator of low density lipoprotein oxidation and endothelial injury. Arterioscler Thromb 11: 1700-1711.
4. Behar-Cohen FF, Gauthier S, El Aouni A, Chapon P, Parel JM, Renard G & Chauvaud D (2001) Methylprednisolone concentrations in the vitreous and the serum after pulse therapy. Retina 21: 48-53.
5. Belágyi J, Pas M, Raspor P, Pesti M & Páli T (1999) Effect of hexavalent chromium on eukaryotic plasma membrane studied by EPR spectroscopy. Biochim Biophys Acta 1421: 175-182.
6. Boyum A (1968) Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl 97: 77-89.
7. Braughler JM (1985) Lipid peroxidation-induced inhibition of γ-aminobutyric acid uptake in rat brain synaptosomes: protection by glucocorticoids. J Neurochem 44: 1282-1288.
8. +)-ATPase, lipid peroxidation and alpha motor neuron function. J Neurosurg 56: 838-844.
9. Bustamante J, Tovar -BA, Montero G & Boveris A (1997) Early redox changes during rat thymocyte apoptosis. Arch Biochem Biophys 337: 121-128.
10. Bykov VL (1989) Morphological analysis of the effect of corticosteroids on the development and course of vaginal candidiasis. Akush Ginekol (Mosk) 2: 35-37.
11. Bykov VL &Velichko EV (1987) Cytological mechanisms of the development of mucosal candidiasis after exposure to a steroid aerosol preparation. Biull Eksp Biol Med 103: 369-371.
12. Calderone RA & Fonzi WA (2001) Virulence factors of Candida albicans. Trends Microbiol 9: 327-335.
13. Camarasa JG & Barnadas M (1982) Occupational contact dermatitis from vitamin K3 sodium bisulphite. Contact Dermatitis 8: 268.
14. Chumnantana R, Yokochi N & Yagi T (2005) Vitamin B6 compounds prevent the death of yeast cells due to MSB, a reactive oxygen generator. Biochim Biophys Acta 1722: 84-91.
15. Czock D, Keller F, Rasche FM & Häussler U (2005) Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clin Pharmacokinet 44: 61-98.
16. Dinis A, Brandao M & Faria A (1988) Occupational contact dermatitis from vitamin K3 sodium bisulphite. Contact Dermatitis 18: 170-171.
17. Ellepola ANB & Samaranayake LP (2001) Inhalational and topical steroids, and oral candidosis: a mini review. Oral Dis 7: 211-216.
18. Emri T, Pócsi I & Szentirmai A (1997) Glutathione metabolism and protection against oxidative stress caused by peroxides in Penicillium chrysogenum. Free Radic Biol Med 23: 809-814.
19. Emri T, Pócsi I & Szentirmai A (1999) Analysis of the oxidative stress response of Penicillium chrysogenum to menadione. Free Rad Res 30: 125-132.
20. Fekete-Forgács K, Gyüre L & Lenkey B (2000) Changes of virulence factors accompanying the phenomenon of induced fluconazole resistance in Candida albicans. Mycoses 43: 273-279.
21. Fischer G (2001) Treatment of vaginitis and vulvitis. Austr Prescr 24: 59-61.
22. Flattery-O'Brien JA, Grant CM & Dawes IW (1997) Stationary-phase regulation of the Saccharomyces cerevisiae SOD2 gene is dependent on additive effects of HAP2/3/4/5- and STRE-binding elements. Mol Microbiol 23: 303-312.
23. Fradin C, Kretschmar M, Nichterlein T, Gaillardin C, d'Enfert C & Hube B (2003) Stage-specific gene expression of Candida albicans in human blood. Mol Microbiol 47: 1523-1543.
24. Fradin C, De Groot P, MacCallum D, Schaller M, Klis F, Odds FC & Hube B (2005) Granulocytes govern the transcriptional response, morphology and proliferation of Candida albicans in human blood. Mol Microbiol 56: 397-415.
25. Franchin G & Diamond B (2006) Pulse steroids: how much is enough? Autoimmun Rev 5: 111-113.
26. Frankel S, Reitman S & Sonnenwirt AC (1970) Gradwohl's Clinical Laboratory Methods and Diagnosis, Vol. 1. 7th edn. C.V. Mosby Company, St Louis.
27. Fukushima C, Matsuse H, Tomari S, Obase Y, Miyazaki Y, Shimoda T & Kohno S (2003) Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone. Ann Allergy Asthma Immunol 90: 646-651.
28. Fulle S, Di Donna S, Puglielli C, Pietrangelo T, Beccafico S, Bellomo R, Protasi F & Fano G (2005) Age-dependent imbalance of the antioxidative system in human satellite cells. Exp Gerontol 40: 189-197.
29. Ghannoum MA & Abu Elteen K (1987) Effect of growth of Candida spp. in the presence of various glucocorticoids on the adherence to human buccal epithelial cells. Mycopathologia 98: 171-178.
30. Grant CM, Maciver FH & Dawes IW (1996) Stationary-phase induction of GLR1 expression is mediated by the yAP-1 transcriptional regulatory protein in the yeast Saccharomyces cerevisiae. Mol Microbiol 22: 739-746.
31. Gyetvai Á, Emri T, Takács K, Dergez T, Fekete A, Pesti M, Pócsi I & Lenkey B (2006) Lovastatin possesses a fungistatic effect against Candida albicans but does not trigger apoptosis in this opportunistic human pathogen. FEMS Yeast Res 6: 1140-1149.
32. Hall ED & Springer JE (2004) Neuroprotection and acute spinal cord injury: a reappraisal. NeuroRx 1: 80-100.
33. Hovi L, Saarinen-Pihkala UM, Vettenranta K & Saxen H (2000) Invasive fungal infections in pediatric bone marrow transplant recipients: single center experience of 10 years. Bone Marrow Transplant 26: 999-1004.
34. Ibrahim AS, Mirbod F, Filler SG et al. (1995) Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 63: 1993-1998.
35. Ichiseki T, Kaneuji A, Katsuda S, Ueda Y, Sugimori T & Matsumoto T (2005) DNA oxidation injury in bone early after steroid administration is involved in the pathogenesis of steroid-induced osteonecrosis. Rheumatology 44: 456-460.
36. Kang MY, Tsuchiya M, Packer L & Manabe M (1998) In vitro study on antioxidant potential of various drugs used in the perioperative period. Acta Anaesthesiol Scand 42: 4-12.
37. Kecskes A, Jahn P, Wendt H, Lange L & Kuhlmann RK (1992) Dose-response relationship of topically applied methylprednisolone aceponate (MPA) in healthy volunteers. Eur J Clin Pharmacol 43: 157-159.
38. Koszdin KL, Shen DD & Bernards CM (2000) Spinal cord bioavailability of methylprednisolone after intravenous and intrathecal administration: the role of P-glycoprotein. Anesthesiology 92: 156-163.
39. Lionakis MS & Kontoyiannis DP (2003) Glucocorticoids and invasive fungal infections. Lancet 362: 1828-1838.
40. Liu TT, Lee RE, Barker KS, Lee RE, Wei L, Homayouni R & Rogers PD (2005) Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob Agents Chemother 49: 2226-2236.
41. Lorenz MC, Bender JA & Fink GR (2004) Transcriptional response of Candida albicans upon internalization by macrophages. Eukaryot Cell 3: 1076-1087.
42. Marsh P & Pflugfelder SC (1999) Topical nonpreserved methylprednisolone therapy for keratoconjunctivitis sicca in Sjögren syndrome. Ophthalmology 106: 811-816.
43. Martini S, Bonechi C, Casolaro M, Corbini G & Rossi C (2006) Drug-protein recognition processes investigated by NMR relaxation data. A study on corticosteroid-albumin interactions. Biochem Pharmacol 71: 858-864.
44. Mavor AL, Thewes S & Hube B (2005) Systemic fungal infections caused by Candida species: epidemiology, infection process and virulence attributes. Curr Drug Targets 6: 863-874.
45. Murina F, Tassan P, Roberti P & Bianco V (2001) Treatment of vulvar vestibulitis with submucous infiltrations of methylprednisolone and lidocaine. An alternative approach. J Reprod Med 46: 713-716.
46. National Committee for Clinical Laboratory Standards (2002) Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; approved standard, second edition. NCCLS document M27-A2. National Committee for Clinical Laboratory Standards, Wayne, PA.
47. Ohia SE, Bagchi M & Stohs SJ (1994) Age-related oxidative damage in Long-Evans rat retina. Res Commun Mol Pathol Pharmacol 85: 21-31.
48. Ohta Y, Okada H, Majima Y & Ishiguro I (1996) Anticataract action of vitamin E: its estimation using an in vitro steroid cataract model. Ophthalmic Res 28 (Suppl 2): 16-25.
49. Okamoto Y, Aoki S & Mataga I (2004) Enhancement of amphotericin B activity against Candida albicans by superoxide radical. Mycopathologia 158: 9-15.
50. Okano M, Yamada M, Ohtsu M, Kawamura N, Sakiyama Y, Aoi K, Gandoh S, Fujita M & Kobayashi K (1999) Successful treatment with methylprednisolone pulse therapy for a life-threatening pulmonary insufficiency in a patient with chronic granulomatous disease following pulmonary invasive aspergillosis and Burkholderia cepacia infection. Respiration 66: 551-554.
51. Pesti M, Gazdag Z & Belágyi J (2000) In vivo interaction of trivalent chromium with yeast plasma membrane, as revealed by EPR spectroscopy. FEMS Microbiol Lett 182: 375-380.
52. Peterson GL (1983) Determination of total protein. Methods Enzymol 91: 95-119.
53. Pócsi I, Prade RA & Penninckx MJ (2004) Glutathione, altruistic metabolite in fungi. Adv Microb Physiol 49: 1-76.
54. 2 and MSB exposed Aspergillus nidulans cultures-linking genome-wide transcriptional changes to cellular physiology. BMC Genomics 6: 182.
55. Ramage G, Vande Walle K, Wickes BL & López-Ribot JL (2001) Biofilm formation by Candida dubliniensis. J Clin Microbiol 39: 3234-3240.
56. Renaud-Vilmer C, Cavelier-Balloy B, Porcher R & Dubertret L (2004) Vulvar lichen sclerosus: effect of long-term topical application of a potent steroid on the course of the disease. Arch Dermatol 140: 709-712.
57. Rhodus NL, Bloomquist C, Liljemark W & Bereuter J (1997) Prevalence, density, and manifestations of oral Candida albicans in patients with Sjögren's syndrome. J Otolaryngol 26: 300-305.
58. Rocha-Pereira P, Santos-Silva A, Rebelo I, Figneiredo A, Quintanilha A &Teixeira F (2004) Erythrocyte damage in mild and severe psoriasis. Br J Dermatol 150: 232-244.
59. Ruzicka T (2006) Methylprednisolone aceponate in eczema and other inflammatory skin disorders-a clinical update. Int J Clin Pract 60: 85-92.
60. Samaranayake LP & MacFarlane TW (1985) On the role of dietary carbohydrates in the pathogenesis of oral candidosis. FEMS Microbiol Lett 27: 1-5.
61. Schmidt AJ, Krieg JC & Vedder H (2002) Differential effects of glucocorticoids and gonadal steroids on glutathione levels in neuronal and glial cell systems. J Neurosci Res 67: 544-550.
62. Slater AF, Nobel CS, Maellaro E, Bustamante J, Kimland M & Orrenius S (1995) Nitrone spin traps and a nitroxide antioxidant inhibit a common pathway of thymocyte apoptosis. Biochem J 306: 771-778.
63. Smith EM, Ritchie JM, Galask R, Pugh EE, Jia J & Ricks-McGillan J (2002) Case-control study of vulvar vestibulitis risk associated with genital infections. Infect Dis Obstet Gynecol 10: 193-202.
64. Sokol-Anderson ML, Brajtburg J & Medoff G (1986) Amphotericin B-induced oxidative damage and killing of Candida albicans. J Infect Dis 154: 76-83.
65. Sokol-Anderson M, Sligh JE Jr, Elberg S, Brajtburg J, Kobayashi GS & Medoff G (1988) Role of cell defense against oxidative damage in the resistance of Candida albicans to the killing effect of amphotericin B. Antimicrob Agents Chemother 32: 702-705.
66. Thomas PA (2003) Current perspectives on ophthalmic mycoses. Clin Microbiol Rev 16: 730-797.
67. Tilbury RN & Quickenden TI (1992) Luminescence from the yeast Candida utilis and comparisons across three genera. J Biolumin Chemilumin 7: 245-253.
68. Tosti A, Piraccini BM, Ghetti E & Colombo MD (2002) Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study. J Am Acad Dermatol 47: 73-76.
69. Vágvölgyi C & Ferenczy L (1991) Isolation of nuclei from Aspergillus nidulans protoplasts. FEMS Microbiol Lett 66: 247-251.
70. Valen G, Kawakami T, Tahepold P et al. (2000) Pretreatment with methylprednisolone protects the isolated rat heart ischaemic and oxidative damage. Free Radic Res 33: 31-43.
71. Varga Zs, Czompa A, Kakuk G & Antus S (2001) Inhibition of superoxide anion release and hydrogen peroxide formation in PMNLs by flavonolignans. Phytother Res 15: 608-612.
72. Veneziano L, Silvani S, Voudouris S & Tosti A (2005) Contact dermatitis due to topical cosmetic use of vitamin K. Contact Dermatitis 52: 113-114.
73. Vree TB, Lagerwerf AJ, Verwey-van Wissen CPWGM & Jongen PJH (1999) High-performance liquid chromatography analysis, preliminary pharmacokinetics, metabolism and renal excretion of methylprednisolone with its C6 and C20 hydroxy metabolites in multiple sclerosis patients receiving high-dose pulse therapy. J Chromatogr B 732: 337-348.
74. Wu T & Samaranayake LP (1999) The expression of secreted aspartyl proteinases of Candida species in human whole saliva. J Med Microbiol 48: 711-720.
75. Wu TG, Wilhelmus KR & Mitchell BM (2003) Experimental keratomycosis in a mouse model. Invest Ophthalmol Vis Sci 44: 210-216.